Annual Gross Profit
$326.75 M
+$62.52 M+23.66%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual gross profit is currently $326.75 million, with the most recent change of +$62.52 million (+23.66%) on 31 December 2023. During the last 3 years, it has risen by +$310.62 million (+1924.98%). BCRX annual gross profit is now at all-time high.BCRX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$113.86 M
+$6.26 M+5.82%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly gross profit is currently $113.86 million, with the most recent change of +$6.26 million (+5.82%) on 30 September 2024. Over the past year, it has increased by +$28.25 million (+33.00%). BCRX quarterly gross profit is now at all-time high.BCRX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$404.59 M
+$28.25 M+7.51%
30 September 2024
Summary:
BioCryst Pharmaceuticals TTM gross profit is currently $404.59 million, with the most recent change of +$28.25 million (+7.51%) on 30 September 2024. Over the past year, it has increased by +$92.55 million (+29.66%). BCRX TTM gross profit is now at all-time high.BCRX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.7% | +33.0% | +29.7% |
| 3 y3 years | +1925.0% | +182.0% | +277.9% |
| 5 y5 years | +1519.0% | +6380.2% | +3851.4% |
BCRX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1925.0% | at high | +182.0% | at high | +277.9% |
| 5 y | 5 years | at high | +1925.0% | at high | +6380.2% | at high | +3851.4% |
| alltime | all time | at high | +5286.5% | at high | +1774.4% | at high | +6625.6% |
BioCryst Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $113.86 M(+5.8%) | $404.59 M(+7.5%) |
| June 2024 | - | $107.60 M(+17.8%) | $376.34 M(+7.4%) |
| Mar 2024 | - | $91.37 M(-0.4%) | $350.28 M(+7.2%) |
| Dec 2023 | $326.75 M(+23.7%) | $91.76 M(+7.2%) | $326.75 M(+4.7%) |
| Sept 2023 | - | $85.61 M(+5.0%) | $312.04 M(+4.5%) |
| June 2023 | - | $81.54 M(+20.2%) | $298.64 M(+5.8%) |
| Mar 2023 | - | $67.84 M(-12.0%) | $282.39 M(+6.9%) |
| Dec 2022 | $264.23 M(+76.3%) | $77.05 M(+6.7%) | $264.23 M(+13.0%) |
| Sept 2022 | - | $72.21 M(+10.6%) | $233.92 M(+15.8%) |
| June 2022 | - | $65.28 M(+31.4%) | $202.09 M(+8.4%) |
| Mar 2022 | - | $49.69 M(+6.3%) | $186.42 M(+24.4%) |
| Dec 2021 | $149.91 M(+829.0%) | $46.74 M(+15.8%) | $149.87 M(+40.0%) |
| Sept 2021 | - | $40.38 M(-18.6%) | $107.07 M(+50.2%) |
| June 2021 | - | $49.62 M(+277.7%) | $71.26 M(+190.7%) |
| Mar 2021 | - | $13.14 M(+233.8%) | $24.52 M(+51.9%) |
| Dec 2020 | $16.14 M(-63.9%) | $3.94 M(-14.0%) | $16.14 M(-67.3%) |
| Sept 2020 | - | $4.58 M(+59.4%) | $49.35 M(+6.1%) |
| June 2020 | - | $2.87 M(-39.6%) | $46.54 M(+3.2%) |
| Mar 2020 | - | $4.75 M(-87.2%) | $45.09 M(+0.8%) |
| Dec 2019 | $44.73 M(+121.7%) | $37.15 M(+2014.6%) | $44.73 M(+336.9%) |
| Sept 2019 | - | $1.76 M(+23.6%) | $10.24 M(+3.2%) |
| June 2019 | - | $1.42 M(-67.7%) | $9.92 M(-52.2%) |
| Mar 2019 | - | $4.40 M(+65.5%) | $20.75 M(+2.8%) |
| Dec 2018 | $20.18 M(-14.1%) | $2.66 M(+85.2%) | $20.18 M(-5.2%) |
| Sept 2018 | - | $1.44 M(-88.3%) | $21.28 M(-22.2%) |
| June 2018 | - | $12.25 M(+219.4%) | $27.35 M(+50.5%) |
| Mar 2018 | - | $3.84 M(+2.0%) | $18.18 M(-22.6%) |
| Dec 2017 | $23.48 M(-0.7%) | $3.76 M(-49.9%) | $23.48 M(-10.6%) |
| Sept 2017 | - | $7.50 M(+143.8%) | $26.25 M(-0.4%) |
| June 2017 | - | $3.08 M(-66.3%) | $26.37 M(-6.0%) |
| Mar 2017 | - | $9.14 M(+40.0%) | $28.05 M(+18.6%) |
| Dec 2016 | $23.65 M(-49.0%) | $6.53 M(-14.3%) | $23.65 M(+9.0%) |
| Sept 2016 | - | $7.62 M(+60.1%) | $21.70 M(-8.5%) |
| June 2016 | - | $4.76 M(+0.4%) | $23.71 M(-46.5%) |
| Mar 2016 | - | $4.74 M(+3.7%) | $44.35 M(-4.3%) |
| Dec 2015 | $46.36 M(+243.8%) | $4.57 M(-52.5%) | $46.36 M(-1.8%) |
| Sept 2015 | - | $9.64 M(-62.1%) | $47.19 M(+15.7%) |
| June 2015 | - | $25.40 M(+276.2%) | $40.79 M(+142.1%) |
| Mar 2015 | - | $6.75 M(+25.0%) | $16.85 M(+25.0%) |
| Dec 2014 | $13.49 M(-21.7%) | $5.40 M(+66.8%) | $13.49 M(-27.6%) |
| Sept 2014 | - | $3.24 M(+121.6%) | $18.63 M(+4.8%) |
| June 2014 | - | $1.46 M(-56.8%) | $17.79 M(+3.8%) |
| Mar 2014 | - | $3.38 M(-67.9%) | $17.14 M(-0.5%) |
| Dec 2013 | $17.23 M | $10.55 M(+341.6%) | $17.23 M(+60.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $2.39 M(+192.4%) | $10.77 M(-23.2%) |
| June 2013 | - | $817.00 K(-76.5%) | $14.02 M(-19.5%) |
| Mar 2013 | - | $3.48 M(-14.8%) | $17.42 M(-33.4%) |
| Dec 2012 | $26.16 M(+33.2%) | $4.08 M(-27.7%) | $26.16 M(-4.2%) |
| Sept 2012 | - | $5.65 M(+34.1%) | $27.30 M(+1.5%) |
| June 2012 | - | $4.21 M(-65.6%) | $26.90 M(+1.8%) |
| Mar 2012 | - | $12.22 M(+133.9%) | $26.43 M(+34.5%) |
| Dec 2011 | $19.64 M(-68.5%) | $5.22 M(-0.5%) | $19.64 M(-36.9%) |
| Sept 2011 | - | $5.25 M(+40.5%) | $31.11 M(-17.8%) |
| June 2011 | - | $3.73 M(-31.3%) | $37.86 M(-9.3%) |
| Mar 2011 | - | $5.43 M(-67.4%) | $41.74 M(-33.0%) |
| Dec 2010 | $62.30 M(-11.1%) | $16.69 M(+39.1%) | $62.30 M(-35.1%) |
| Sept 2010 | - | $12.00 M(+57.6%) | $95.95 M(+1.5%) |
| June 2010 | - | $7.62 M(-70.7%) | $94.50 M(+3.1%) |
| Mar 2010 | - | $25.98 M(-48.4%) | $91.67 M(+30.9%) |
| Dec 2009 | $70.05 M(+23.8%) | $50.35 M(+377.4%) | $70.05 M(+255.7%) |
| Sept 2009 | - | $10.55 M(+120.3%) | $19.69 M(+115.3%) |
| June 2009 | - | $4.79 M(+9.8%) | $9.15 M(+109.8%) |
| Mar 2009 | - | $4.36 M(+506.3%) | $4.36 M(+31.6%) |
| Dec 2008 | $56.56 M(+1785.4%) | - | - |
| Mar 2000 | - | $719.00 K(+619.0%) | $3.31 M(+3.7%) |
| Dec 1999 | $3.00 M(-56.5%) | $100.00 K(-1.0%) | $3.19 M(-11.1%) |
| Sept 1999 | - | $101.00 K(-95.8%) | $3.59 M(-62.5%) |
| June 1999 | - | $2.39 M(+298.7%) | $9.59 M(+26.2%) |
| Mar 1999 | - | $600.00 K(+20.0%) | $7.60 M(+5.6%) |
| Dec 1998 | $6.90 M(+331.3%) | $500.00 K(-91.8%) | $7.20 M(+5.9%) |
| Sept 1998 | - | $6.10 M(+1425.0%) | $6.80 M(+580.0%) |
| June 1998 | - | $400.00 K(+100.0%) | $1.00 M(-44.4%) |
| Mar 1998 | - | $200.00 K(+100.0%) | $1.80 M(-263.6%) |
| Dec 1997 | $1.60 M(-23.8%) | $100.00 K(-66.7%) | -$1.10 M(-35.3%) |
| Sept 1997 | - | $300.00 K(-75.0%) | -$1.70 M(+6.3%) |
| June 1997 | - | $1.20 M(-144.4%) | -$1.60 M(+77.8%) |
| Mar 1997 | - | -$2.70 M(+440.0%) | -$900.00 K(-145.0%) |
| Dec 1996 | $2.10 M(-133.3%) | -$500.00 K(-225.0%) | $2.00 M(-146.5%) |
| Sept 1996 | - | $400.00 K(-78.9%) | -$4.30 M(-4.4%) |
| June 1996 | - | $1.90 M(+850.0%) | -$4.50 M(-27.4%) |
| Mar 1996 | - | $200.00 K(-102.9%) | -$6.20 M(+3.3%) |
| Dec 1995 | -$6.30 M(+46.5%) | -$6.80 M(-3500.0%) | -$6.00 M(+900.0%) |
| Sept 1995 | - | $200.00 K(0.0%) | -$600.00 K(-68.4%) |
| June 1995 | - | $200.00 K(-50.0%) | -$1.90 M(-40.6%) |
| Mar 1995 | - | $400.00 K(-128.6%) | -$3.20 M(-27.3%) |
| Dec 1994 | -$4.30 M | -$1.40 M(+27.3%) | -$4.40 M(+46.7%) |
| Sept 1994 | - | -$1.10 M(0.0%) | -$3.00 M(+57.9%) |
| June 1994 | - | -$1.10 M(+37.5%) | -$1.90 M(+137.5%) |
| Mar 1994 | - | -$800.00 K | -$800.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual gross profit year-on-year change?
- What is BioCryst Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly gross profit year-on-year change?
- What is BioCryst Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM gross profit year-on-year change?
What is BioCryst Pharmaceuticals annual gross profit?
The current annual gross profit of BCRX is $326.75 M
What is the all time high annual gross profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual gross profit is $326.75 M
What is BioCryst Pharmaceuticals annual gross profit year-on-year change?
Over the past year, BCRX annual gross profit has changed by +$62.52 M (+23.66%)
What is BioCryst Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of BCRX is $113.86 M
What is the all time high quarterly gross profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly gross profit is $113.86 M
What is BioCryst Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, BCRX quarterly gross profit has changed by +$28.25 M (+33.00%)
What is BioCryst Pharmaceuticals TTM gross profit?
The current TTM gross profit of BCRX is $404.59 M
What is the all time high TTM gross profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM gross profit is $404.59 M
What is BioCryst Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, BCRX TTM gross profit has changed by +$92.55 M (+29.66%)